Eli Lilly (NYSE:LLY) shares snapped six straight days of losses as the stock closed 1.39% higher, at $812.76 on Friday.  The ...

The FDA says state-licensed compounding pharmacies must immediately stop making compound versions of GLP-1 drugs. Larger, national licensed facilities making compound versions of Zepbound have until ...

Researchers have conducted the first national survey on public awareness and perceptions of food, health, and Food is ...

Television personality and surgeon Dr. Mehmet Oz is scheduled to appear on Friday before the Senate Finance Committee, on which Warren sits. The panel will hold a confirmation hearing for his ...

Eli Lilly plans to launch Mounjaro, its blockbuster diabetes drug, in countries like China, India, Brazil and Mexico by 2026, ...

Late-breaking results presented at AAD show 80% or more scalp hair coverage at Week 36 in 42.4% of adolescents receiving baricitinib 4 mg INDIANAPOLIS /PRNewswire/ -- Late-breaking results from Eli ...

The global antidiabetics market is on a strong growth trajectory, with sales projected to soar from USD 106.3 billion in 2024 to USD 298.2 billion by 2034. This substantial increase reflects a robust ...

If you’ve been to the doctor and received treatment, that treatment was very likely built on NIH-supported research.

FHLC offers diversification with 368 U.S. large-cap holdings, outperforming peer funds. See why I rate the fund a buy.

This growth comes on the back of a steady market performance from 2017 to 2022, where the injection pen sector achieved a ...

California dedicated $100 to manufacturing insulin for diabetic residents. That effort is taking longer than Gov. Gavin ...